Email this article Serum lipoprotein changes in women over the age of 35 years using combined oral contraceptives
- Authors: Tarasova M.A.1,2, Soukhorukova A.V.1,2, Bodul A.S.1,2
-
Affiliations:
- I.P. Pavlov Medical University
- D.O. Ott Institute of Obstetrics & Gynecology
- Issue: Vol 48, No 5S (1999)
- Pages: 157-157
- Section: Articles
- URL: https://journals.rcsi.science/jowd/article/view/101453
- DOI: https://doi.org/10.17816/JOWD101453
- ID: 101453
Cite item
Full Text
Abstract
The reduction of steroid dose has led to the increase in safety of combined oral contraceptives (COCs) use. Since then modern “low-dose” formulations of COCs have been widely recommended not only for young women but also for women of late reproductive age.
Full Text
##article.viewOnOriginalSite##About the authors
M. A. Tarasova
I.P. Pavlov Medical University; D.O. Ott Institute of Obstetrics & Gynecology
Author for correspondence.
Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg
A. V. Soukhorukova
I.P. Pavlov Medical University; D.O. Ott Institute of Obstetrics & Gynecology
Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg
A. S. Bodul
I.P. Pavlov Medical University; D.O. Ott Institute of Obstetrics & Gynecology
Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg
References
Supplementary files
